Background: People who inject drugs (PWID) living with HIV often experience sub-optimal antiretroviral therapy (ART) treatment outcomes, including HIV plasma viral load (PVL) rebound. While previous studies have identified risk factors for PVL rebound among PWID, no study has examined the perspectives of PWID who have experienced PVL rebound episodes. We conducted an ethno-epidemiological study to investigate the circumstances surrounding the emergence of rebound episodes among PWID in Vancouver, BC, Canada. Methods Comprehensive clinical records linked to a community-based prospective observational cohort of HIV-positive drug users were used to identify PWID...
Objective—Studies have demonstrated the central function of plasma HIV-1 RNA viral load (pVL) level...
Background. Among people living with HIV/AIDS, illicit drug use is a risk for sub-o...
Background: Despite the availability of antiretroviral therapy (ART), suboptimal treatment outcomes ...
Background: People who inject drugs (PWID) living with HIV often experience sub-optimal antiretrovir...
INTRODUCTION: Evidence is needed to improve HIV treatment outcomes for individuals who use injection...
HIV Treatment as Prevention (TasP) initiatives promote antiretroviral therapy (ART) access and optim...
We investigated whether drug-related behaviors predicted antiretroviral therapy (ART) discontinuatio...
Antiretroviral therapy (ART) dispensing is strongly associated with treatment adherence. Among illic...
HIV-positive people who use illicit drugs typically achieve lower levels of adherence to antiretrovi...
Objective: Given that people who use illicit drugs (PWUD) often engage in prohibited income generati...
We examined the relationship between residential eviction and exhibiting detectable plasma HIV-1 RNA...
Background Previous studies suggest that active drug use may compromise HIV treatment among HIV-p...
HIV Treatment as Prevention (TasP) initiatives promote antiretroviral therapy (ART) access and optim...
Background: Despite the development of antiretroviral therapy (ART), injection drug users (IDU) cont...
BackgroundSelf-reported antiretroviral therapy (ART) adherence measures that are associated with pla...
Objective—Studies have demonstrated the central function of plasma HIV-1 RNA viral load (pVL) level...
Background. Among people living with HIV/AIDS, illicit drug use is a risk for sub-o...
Background: Despite the availability of antiretroviral therapy (ART), suboptimal treatment outcomes ...
Background: People who inject drugs (PWID) living with HIV often experience sub-optimal antiretrovir...
INTRODUCTION: Evidence is needed to improve HIV treatment outcomes for individuals who use injection...
HIV Treatment as Prevention (TasP) initiatives promote antiretroviral therapy (ART) access and optim...
We investigated whether drug-related behaviors predicted antiretroviral therapy (ART) discontinuatio...
Antiretroviral therapy (ART) dispensing is strongly associated with treatment adherence. Among illic...
HIV-positive people who use illicit drugs typically achieve lower levels of adherence to antiretrovi...
Objective: Given that people who use illicit drugs (PWUD) often engage in prohibited income generati...
We examined the relationship between residential eviction and exhibiting detectable plasma HIV-1 RNA...
Background Previous studies suggest that active drug use may compromise HIV treatment among HIV-p...
HIV Treatment as Prevention (TasP) initiatives promote antiretroviral therapy (ART) access and optim...
Background: Despite the development of antiretroviral therapy (ART), injection drug users (IDU) cont...
BackgroundSelf-reported antiretroviral therapy (ART) adherence measures that are associated with pla...
Objective—Studies have demonstrated the central function of plasma HIV-1 RNA viral load (pVL) level...
Background. Among people living with HIV/AIDS, illicit drug use is a risk for sub-o...
Background: Despite the availability of antiretroviral therapy (ART), suboptimal treatment outcomes ...